# To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions

> **NCT06696209** · NA · RECRUITING · sponsor: **Portuguese Oncology Institute, Coimbra** · enrollment: 1290 (estimated)

## Conditions studied

- Premalignant Conditions
- Malignant Lesions
- Gastric
- Esophageal
- Duodenal

## Interventions

- **OTHER:** Analysis of the withdrawal time of the Upper Gastrointestinal Endoscopy
- **OTHER:** Analysis of the total time of the Upper Gastrointestinal Endoscopy
- **OTHER:** Upper gastrointestinal endoscopy: Common Practices

## Key facts

- **NCT ID:** NCT06696209
- **Lead sponsor:** Portuguese Oncology Institute, Coimbra
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-07
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 1290 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06696209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06696209, "To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06696209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*